drugset

drugset / Trial / NCT00767793

A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650)

NCT00767793 ↗

Phase 1 Completed 84 enrolled Merck Sharp & Dohme LLC

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of INS117548 ophthalmic solution.

Timeline

Start: 2008-09
Primary completion: 2009-05
Completion: 2009-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	INS117548	Unknown	—	Other

Indications